SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kapildev K. Arora, Sunny P. Bhardwaj, Pinal Mistry, Raj Suryanarayanan, Modulating the Dehydration Conditions of Adefovir Dipivoxil Dihydrate to Obtain Different Physical Forms of Anhydrate, Journal of Pharmaceutical Sciences, 2015, 104, 3
  2. 2
    Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Chang Wook Kim, Chang Don Lee, Sang Hoon Park, Myung Seok Lee, Choong Kee Park, Hee Bok Chae, Moon Young Kim, Soon Koo Baik, Yun Soo Kim, Ju Hyun Kim, Jung Il Lee, Jin Woo Lee, Sun Pyo Hong, Soon Ho Um, Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial, Liver International, 2013, 33, 2
  3. 3
    Y. Li, Y. Zhang, J.-P. Wang, J.-Q. Lian, X.-F. Bai, Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil, Journal of Viral Hepatitis, 2013, 20,
  4. 4
    YongFa Chen, Ting Ju, Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B, International Journal of Infectious Diseases, 2012, 16, 3, e152

    CrossRef

  5. 5
    Marco Montagnani, Marina Giandinoto, Andrea Lisotti, Silvia Galli, Francesco Azzaroli, Federica Buonfiglioli, Laura Turco, Rita Aldini, Giuseppe Mazzella, High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On, Digestive Diseases and Sciences, 2012, 57, 2, 561

    CrossRef

  6. 6
    N. Gara, X. Zhao, M. T. Collins, W. H. Chong, D. E. Kleiner, T. Jake Liang, M. G. Ghany, J. H. Hoofnagle, Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2012, 35, 11
  7. 7
    Yoon-Seon Lee, Young-Hwa Chung, Jeong A Kim, Young Joo Jin, Won Hyung Park, Sung Eun Kim, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh, rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy, Journal of Gastroenterology and Hepatology, 2012, 27, 2
  8. 8
    Melanie Deutsch, Nikolaos Papadopoulos, Spilios Manolakopoulos, Emilia Hatziyanni, Dimitrios Vassilopoulos, Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load, European Journal of Gastroenterology & Hepatology, 2011, 23, 1, 109

    CrossRef

  9. 9
    Spilios Manolakopoulos, Athanasia Striki, Melanie Deutsch, Maria Mela, Ioannis Ketikoglou, Dimitrios Tzourmakliotis, Emanuel K. Manesis, George V. Papatheodoridis, Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients, Liver International, 2011, 31, 10
  10. 10
    A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse, H. L.-Y. Chan, Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
  11. 11
    Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, X. Huang, R. Xie, S. Ge, J. Hu, Z. Jiang, M. Zhu, V. W.-S. Wong, H. L.-Y. Chan, Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy, Alimentary Pharmacology & Therapeutics, 2011, 34, 3
  12. You have free access to this content12
    George V. Papatheodoridis, Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues, Liver International, 2011, 31,
  13. 13
    Hai-Tang Xie, Guang-Ji Wang, Mei-Juan Xu, Yuan-Wei Jia, Hao Li, Jian-Guo Sun, Peng Li, A New LC–MS–MS Method for Quantitative Analysis of Adefovir, and Its Use for Pharmacokinetic Studies in Healthy Chinese Volunteers, Chromatographia, 2010, 71, 7-8, 587

    CrossRef

  14. 14
    Themistoklis G Vassiliadis, Olga Giouleme, Georgios Koumerkeridis, Haralabos Koumaras, Konstantinos Tziomalos, Kalliopi Patsiaoura, Nikolaos Grammatikos, Alexandros Mpoumponaris, Dimitrios Gkisakis, Konstantinos Theodoropoulos, Athanasia Panderi, Panagiotis Katsinelos, Nikolaos Eugenidis, Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: A 4-year study, Journal of Gastroenterology and Hepatology, 2010, 25, 1
  15. 15
    A. Kahloun, M. Bourlière, F. Zoulim, Bithérapie par analogues dans le traitement de l’hépatite chronique B : de novo ou en cas d’échec, Gastroentérologie Clinique et Biologique, 2010, 34, S126

    CrossRef

  16. 16
    Ester Lopez-Suñé, Montse Tuset, Montse Laguno, Asunción Moreno, José M. Miró, Características de los fármacos antivíricos activos frente al virus de la hepatitis y el virus de la influenza: actualización 2009, Enfermedades Infecciosas y Microbiología Clínica, 2010, 28, 4, 253.e1

    CrossRef

  17. 17
    Hie-Won L. Hann, Stephen R. Dunn, Meejin Ahn, So Young Park, Question of ALT flare during switch to adefovir from lamivudine: A single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009), Journal of Medical Virology, 2010, 82, 9
  18. 18
    In Hee Kim, Seok Lee, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Chang Soo Choi, Haak Cheoul Kim, Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naïve Patients with HBeAg Positive Chronic Hepatitis B, Journal of Korean Medical Science, 2010, 25, 5, 738

    CrossRef

  19. 19
    Norah A. Terrault, Benefits and risks of combination therapy for hepatitis B, Hepatology, 2009, 49, S5
  20. 20
    Hyun Wook Jung, Moon Seok Choi, Kap Hyun Kim, Sung Hyun Park, Kwak Keum Yeon, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients, The Korean Journal of Hepatology, 2009, 15, 1, 52

    CrossRef

  21. 21
    Emmet B. Keeffe, Douglas T. Dieterich, Steven-Huy B. Han, Ira M. Jacobson, Paul Martin, Eugene R. Schiff, Hillel Tobias, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update, Clinical Gastroenterology and Hepatology, 2008, 6, 12, 1315

    CrossRef

  22. 22
    Satoshi Shakado, Hiroshi Watanabe, Takashi Tanaka, Daisuke Morihara, Shinya Nishizawa, Shinjiro Inomata, Syuichi Ueda, Teruo Matsumoto, Akira Anan, Yasuaki Takeyama, Makoto Irie, Kaoru Iwata, Tetsuro Sohda, Shotaro Sakisaka, Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B, Hepatology International, 2008, 2, 3, 361

    CrossRef

  23. 23
    Corrigenda, Alimentary Pharmacology & Therapeutics, 2008, 27, 6
  24. 24
    Corrigenda, Alimentary Pharmacology & Therapeutics, 2008, 27, 6
  25. 25
    Corrigenda, Alimentary Pharmacology & Therapeutics, 2008, 27, 6
  26. 26
    Erratum, Alimentary Pharmacology & Therapeutics, 2008, 27, 6
  27. 27
    James Fung, Ching-Lung Lai, Man-Fung Yuen, New paradigms for the treatment of chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2008, 23, 8pt1